MitoPower is a biopharmaceutical startup focusing on developing innovative therapies for patients with severe mitochondrial dysfunction. The company collaborates with academic institutions in the fields of energy metabolism, liver biology, and immune function. Additionally, it has established partnerships with leading CROs in pharmaceutical development, pre-clinical pharmacology, and toxicology. Established in 2017, MitoPower's leadership team brings extensive expertise in drug development, specifically in liver diseases, covering medicinal chemistry, pharmacology, toxicology, and regulatory affairs. The company operates in the biopharma and biotechnology industries.
MitoPower
Therapeutics for patients with severe mitochondrial dysfunction
Founded 2017
Palo Alto, United States
5 employees
Biopharma, Biotechnology
Palo Alto, United States
5 employees
Biopharma, Biotechnology
General Information
Get notified when MitoPower moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track MitoPower
Get real-time alerts for funding, hiring, news, and 40+ signal types.
Start Tracking — FreeDiscover More
United States Market
Biopharma
About MitoPower
Taxonomy: Biopharmaceuticals, Mitochondrial dysfunction, Therapeutic development, Drug development, Academic collaborations, Liver diseases, Energy metabolism, Immune function, Pre-clinical pharmacology, Toxicology, Medicinal chemistry, Regulatory affairs, CRO partnerships, Pharmaceutical development, Expert leadership
No funding data available for MitoPower yet.
Get notified when MitoPower raises fundingMitoPower Alternatives & Competitors
MitoPower vs
MitoPower vs
Pharmaron
China
Premier life science service provider
Post Ipo Equity
1860 employees
Biotechnology, Pharmaceutical
MitoPower vs
Prisys Biotechnologies
China
Better Human Health by Primate Translational Sciences.
30 employees
Biotechnology, Pharmaceutical
FAQ About MitoPower
Therapeutics for patients with severe mitochondrial dysfunction
MitoPower was founded in 2017.
MitoPower is headquartered in Palo Alto, United States.
MitoPower operates in the following industries: Biopharma, Biotechnology.
MitoPower has approximately 5 employees.
Top alternatives and competitors to MitoPower include LYO-X AG, Pharmaron, Prisys Biotechnologies, Aurigon, Yecuris Corporation. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MitoPower and LYO-X AG are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors MitoPower and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.